
Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
Netflix's 'Lord of the Flies' show blends 'Adolescence' and 'Yellowjackets'
American tourists left stranded in the Caribbean following flight cancellations after airspace closed for Maduro operation
Mom finds out she has cancer after noticing something was off while breastfeeding
The Artemis II launch is tonight. Here's how to watch it live.
Woman leaves bachelorette trip after trusting her gut about sketchy men partying it up with friends
21 Things You Ought to Never Tell Your Childless Companion
Japan prepares to restart world's biggest nuclear plant, 15 years after Fukushima
What to know about King Charles III's cancer treatment and his message to the public
Poll: Only 25% of Americans think Trump has 'followed through' on his promise to release the Epstein files













